Lebret, Thierry
Paoletti, Xavier
Pignot, Geraldine
Roumiguié, Mathieu
Colombel, Marc
Savareux, Laurent
Verhoest, Grégory
Guy, Laurent
Rigaud, Jérome
De Vergie, Stéphane
Poinas, Grégoire
Droupy, Stéphane
Kleinclauss, François
Courtade-Saïdi, Monique
Piaton, Eric
Radulescu, Camelia
Rioux-Leclercq, Nathalie
Kandel-Aznar, Christine
Renaudin, Karine
Cochand-Priollet, Béatrix
Allory, Yves
Nivet, Sébastien
Rouprêt, Morgan
Article History
Received: 22 March 2023
Accepted: 1 July 2023
First Online: 22 July 2023
Declarations
:
: Thierry Lebret declares receiving consulting fees, honoraria, and/or support for attending meetings from Astellas Pharma, Bayer, Bristol Myer Squibb, IPSEN, MSD, Roche, and VitaDX. Grégoire Poinas declares receiving support from VitaDX to conduct this study. Monique Courtade-Saïdi declares being the president of the French Society for Cytology and having received payment for expert testimony from VitaDX. Nathalie Rioux-Leclercq declares having received grants from INCa (the French National Cancer Institute), for a translational study and from the Nominoë Foundation to develop digital pathology at the CHU Rennes. Karine Renaudin declares having received payments from MSD. Béatrix Cochand-Priollet declares receiving support for attending meetings. Nivet declares having shares and being employed by VitaDX. Morgan Rouprêt declares having received consulting fees from Cepheid, OncoDiag, Astellas Pharma, Janssen, IPSEN, and VitaDX. All other authors have nothing to declare.